The antipsychotic, quetiapine [AstraZeneca], has been approved in Mexico for use in manic episodes

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1394, 2003-01, pp. : 22-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An IV formulation of esomeprazole [Nexium] has been launched in the UK by AstraZeneca

By  

Inpharma, Vol. 1, Iss. 1431, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

AstraZeneca has been fined 60 million by the European Commission (EC) for anticompetitive conduct regarding its proton pump inhibitor omeprazole

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 481, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Rosuvastatin [Crestor; AstraZeneca] has received a positive opinion in Japan

By  

Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

An agreement reached with AstraZeneca will allow

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 387, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

AstraZENeca and the A&RT of metadata maintenance

By Frost Paul A A.  

Pharmaceutical Programming, Vol. 3, Iss. 2, 2010-12 ,pp. : 57-63

Maney Publishing

Access to resources Recommend Favorite